FIELD: medicine.
SUBSTANCE: present invention offers a composition for treating tumours containing: (1) allogenic or xenogenic tumour cells; (2) a lysate of syngeneic tumour cell and (3) a pharmaceutically acceptable excipient wherein allogenic or xenogenic cells are tumour cells of the same or similar class as patient's tumour cells.
EFFECT: invention enables selecting a type of tumour cells/tissue for transplantation of tumour/cancer tissue/cell of one individual to another, enables avoiding rejection of the transplanted tissue/cell, and also promotes higher immunological alarm with respect to peptides being common for these tumour/cancer growths and other tumours having similar peptides.
8 cl, 1 ex, 9 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR OBTAINING VACCINE FOR TREATING TUBERCULOSIS AND OTHER INTRACELLULAR INFECTIOUS DISEASES AND VACCINE OBTAINED ACCORDING TO DECLARED METHOD | 2001 |
|
RU2262950C2 |
| IMPROVED COMPOSITION FOR INHIBITION OF TUMOUR CELL PROLIFERATION | 2011 |
|
RU2565542C2 |
| METHODS AND COMPOSITIONS FOR TREATING TUMORS | 2017 |
|
RU2741786C2 |
| LINE OF CELLS OF HUMAN MELANOMA KG, SECRETING RECOMBINANT GRANULOCYTIC MACROFAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2362805C1 |
| HUMAN MELANOMA CELL LINE PG WHICH SECRETES RECOMBINANT GRANULOCYTIC-MACROPHAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2395570C1 |
| HUMAN MELANOMA CELL LINE ILG WHICH SECRETES RECOMBINANT GRANULOCYTIC-MACROPHAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2395574C1 |
| INTRODUCTION OF DENDRITIC CELLS EXPOSED TO PARTIAL AGING IN VITRO, FOR TUMOUR TREATMENT | 2003 |
|
RU2348418C2 |
| COMPOSITIONS AND METHODS FOR WT1-SPECIFIC IMMUNOTHERAPY | 1999 |
|
RU2237674C2 |
| METHODS OF PREDICTING THE APPLICABILITY OF DISEASE-SPECIFIC AMINO ACID MODIFICATIONS FOR IMMUNOTHERAPY | 2018 |
|
RU2799341C2 |
| METHOD OF ANTITUMOUR IMMUNOTHERAPY | 2012 |
|
RU2530523C2 |
